Insiders · AYLA

AYLA insider transactions

Ayala Pharmaceuticals Inc. (AYLA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for AYLA

• 954d
  SEC Form 3 filed by new insider Martell Bridget A

  3 - Old Ayala, Inc (0001797336) (Issuer)
• 954d
  SEC Form 3 filed by new insider Orbach Pini

  3 - Old Ayala, Inc (0001797336) (Issuer)
• 955d
  SEC Form 3 filed by new insider Golan Roy

  3 - Old Ayala, Inc (0001797336) (Issuer)
• 1236d
  SEC Form 4: Amoon Growth Fund Limited Partnership returned 2,991,473 shares to the company

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1236d
  SEC Form 4: Maimon Yossi returned 69,872 shares to the company, closing all direct ownership in the company

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1236d
  SEC Form 4 filed by Spiegel Robert J.

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1236d
  SEC Form 4: Sidransky David returned 250 shares to the company

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1236d
  SEC Form 4: Mamluk Roni returned 265,345 shares to the company, closing all direct ownership in the company

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1236d
  SEC Form 4 filed by Bisker-Leib Vered

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1236d
  SEC Form 4 filed by Goldberg Murray A

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1236d
  SEC Form 4: Gordon Gary B. returned 58,520 shares to the company, closing all direct ownership in the company

  4 - Old Ayala, Inc (0001797336) (Issuer)
• 1458d
  SEC Form 4 filed by Sidransky David

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1458d
  SEC Form 4 filed by Goldberg Murray A

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1458d
  SEC Form 4 filed by Spiegel Robert J.

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1458d
  SEC Form 4 filed by Bisker-Leib Vered

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1488d
  SEC Form 4: Gordon Gary B. was granted 50,000 shares, increasing direct ownership by 587% to 58,520 units

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1488d
  SEC Form 4: Mamluk Roni was granted 120,000 shares, increasing direct ownership by 83% to 265,345 units

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1488d
  SEC Form 4: Maimon Yossi was granted 50,000 shares, increasing direct ownership by 252% to 69,872 units

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1619d
  SEC Form 4 filed by Gordon Gary B.

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1619d
  SEC Form 4 filed by Mamluk Roni

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1619d
  SEC Form 4 filed by Maimon Yossi

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1824d
  SEC Form 4 filed by Bisker-Leib Vered

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1824d
  SEC Form 4 filed by Spiegel Robert J.

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1824d
  SEC Form 4 filed by SIDRANSKY DAVID

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1824d
  SEC Form 4 filed by GOLDBERG MURRAY A

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1824d
  SEC Form 4 filed by Sone Todd

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1922d
  SEC Form 4: David Sidransky bought $3,700 worth of Common Stock (250 units at $14.80)

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1932d
  SEC Form 4: B. Gary Gordon exercised 3,000 units of Common Stock at a strike of $5.16 and sold $52,385 worth of Common Stock (3,000 units at $17.46)

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1934d
  SEC Form 4: Roni Mamluk sold $617,215 worth of Common Stock (33,126 units at $18.63), decreasing ownership by 19% to 145,345 units

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1967d
  SEC Form 4: Roni Mamluk sold $313,795 worth of Common Stock (20,872 units at $15.03), decreasing ownership by 10% to 178,471 units

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)
• 1967d
  SEC Form 4: B. Gary Gordon exercised 3,000 units of Common Stock at a strike of $5.16 and sold $45,084 worth of Common Stock (3,000 units at $15.03)

  4 - Ayala Pharmaceuticals, Inc. (0001797336) (Issuer)